The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1
Open Access
- 1 June 2007
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (6), 2107-2114
- https://doi.org/10.1210/jc.2006-2466
Abstract
Context: Autoimmune polyendocrine syndrome type 1 (APS1) is an autosomal recessive disorder caused by mutations in the autoimmune regulator gene. Hypoparathyroidism occurs in 80% of patients with APS1 and has been suggested to result from an autoimmune reaction against the calcium-sensing receptor (CaSR) on parathyroid cells. However, the detection of CaSR antibodies in APS1 remains controversial, with some studies disputing the relevance of the receptor as an autoantigen. Objective: The aim of this study was to analyze a defined set of APS1 patient sera for the presence of CaSR antibodies using different assay systems. Results: APS1 patients and individuals with other autoimmune disorders along with healthy subjects were tested for antibody binding to the CaSR. In an immunoprecipitation assay with the CaSR expressed in human embryonic kidney 293 cells, 12 of 14 (85.7%) APS1 and two of 28 (7.1%) Graves’ disease patients were considered positive for CaSR antibodies. The prevalence of receptor antibodies was significantly greater than that in the cohort of healthy individuals only in the APS1 patient group (P < 0.0001). In a flow cytometry assay, seven of 14 (50.0%) APS1 patient sera showed binding to the extracellular domain of the CaSR. The prevalence of receptor antibodies in the APS1 patient group was significantly greater than that in the group of healthy controls (P = 0.023). No CaSR antibodies could be detected in any patients or controls using a radiobinding assay. Conclusion: The CaSR is an autoantigen in APS1, but detection of antibodies against the receptor appears to be influenced by the assay system used.Keywords
This publication has 32 references indexed in Scilit:
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal DystrophyJournal of Clinical Endocrinology & Metabolism, 2006
- Localization of the APECED protein in distinct nuclear structuresHuman Molecular Genetics, 1999
- The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factorTrends in Biochemical Sciences, 1998
- An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domainsNature Genetics, 1997
- Positional cloning of the APECED geneNature Genetics, 1997
- The PHD finger: Implications for chromatin-mediated transcriptional regulationTrends in Biochemical Sciences, 1995
- An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21Nature Genetics, 1994
- 21-hydroxylase, a major autoantigen in idiopathic Addison's diseaseThe Lancet, 1992
- Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylaseThe Lancet, 1992
- Autoimmune Polyglandular SyndromesPediatric Annals, 1980